Advertisement
Perspective

Perspective Perspectives are commissioned from an expert and discuss the clinical practice or public health implications of a published study. The original publication must be freely available online.

See all article types »

Inhibition of EGFR Signaling: All Mutations Are Not Created Equal

  • Published: November 29, 2005
  • DOI: 10.1371/journal.pmed.0020377

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.

Linked Articles

Oncogenic Transformation by Inhibitor-Sensitive and -Resistant EGFR Mutants

Heidi Greulich, Tzu-Hsiu Chen, Whei Feng, Pasi A Jänne, James V Alvarez, Mauro Zappaterra, Sara E Bulmer, David A Frank, William C Hahn, William R Sellers, Matthew Meyerson
Research Article | published 4 Oct 2005 | PLOS Medicine
doi:10.1371/journal.pmed.0020313